Stents Drug Eluting

This channel includes news and new technology innovations for drug eluting stents (DES). This includes both metallic and bioresorbable drug-eluting stents and related clinical trial data.

News | November 13, 2014

Nov. 13, 2014 — Optimizing the treatment of coronary artery disease with a new foundation for future stent...

Technology | November 04, 2014

November 4, 2014 — The U.S. Food and Drug Administration (FDA) has cleared the Abbott family of Xience everolimus-...

News | October 20, 2014

October 20, 2014 — Boston Scientific Corp. has initiated the PLATINUM Diversity trial to evaluate the clinical...

News | September 26, 2014
September 26, 2014 — A first-of-its kind study comparing the safety and efficacy of biodegradable polymer sirolimus-...
Svelte Coronary DES DIRECT II Trial Six Month Results TCT 2014
News | September 25, 2014

September 25, 2014 — Svelte Medical Systems reported that its...

bioresorbable stents, dissolving stents, Absorb stent, BVS

Abbott has spearheaded bioresorbable stent technology with the development with its BVS. By far the BVS has the most clinical experience, with more than 13,000 patients around the world having been treated with the device.

Feature | Stents Bioresorbable | September 03, 2014 | Dave Fornell
Patient Enrollment REDUCE Sudy Combo Dual Therapy Stent OrbusNeich
News | August 15, 2014

August 15, 2014 — OrbusNeich announced first patient enrollment in the Randomized Evaluation of short-term Dual anti...

News | July 30, 2014

July 30, 2014 — OrbusNeich announced the first patient has been enrolled in the Multinational Abluminal Sirolimus...

News | July 15, 2014

July 15, 2014 — Micell Technologies Inc. announced the United States Patent and Trademark Office (USPTO) has issued...

Blog | Cardiovascular Business | July 09, 2014

A big fly in the ointment for widespread adoption of many new technologies is cost. In today’s cost-conscience...

Feature | July 09, 2014

A big fly in the ointment for widespread adoption of many new technologies is cost. In today’s cost-...

OrbusNeich Patient Enrollment Completion REMEDEE Registry Combo Stent
News | June 24, 2014

June 24, 2014 — OrbusNeich announced the completion of enrollment in the prospective, multicenter, all-comers...

News | June 10, 2014

June 10, 2014 — Ariad Pharmaceuticals Inc. and Medinol Ltd. earlier this year initiated...

Boston Scientific Promus Premier Drug Eluting Stent
News | May 01, 2014

May 1, 2014 — Boston Scientific Corp. has launched the Promus Premier Everolimus-Eluting Platinum Chromium Coronary...

Biolimus Everolimus Stent Clinical Trial ACC.14
News | April 04, 2014

April 4, 2014 — A new stent covered with...

Overlay Init